About
Research
Products
Investors
Careers
Agenda
fr
Press Releases
Our latest news and press releases
All
2018
2017
2016
2015
2014
11
Apr
2018
02:00 E.S.T.
Cellectis to Present Data at the 2018 AACR Annual Meeting
Read more
10
Apr
2018
16:10 E.S.T.
Cellectis Announces Closing of Follow-On Offering
Read more
09
Apr
2018
08:30 E.S.T.
Allogene Therapeutics Completes Agreement for Pfizer’s Allogeneic CAR T Immuno-oncology Portfolio
Read more
04
Apr
2018
20:30 E.S.T.
Cellectis Announces Pricing of Follow-On Offering
Read more
03
Apr
2018
16:51 E.S.T.
Cellectis Announces Launch of Follow-On Offering
Read more
03
Apr
2018
08:10 E.S.T.
Cellectis and Allogene Therapeutics Intend to Continue Strategic Cancer Immunotherapy Collaboration to Accelerate Development and Commercialization of Allogeneic Off-the-Shelf CAR T Therapies
Read more
13
Mar
2018
16:30 E.S.T.
Dr. Mathieu Simon to Retire as Cellectis’ Chief Operating Officer; Elsy Boglioli Named as Successor
Read more
12
Mar
2018
16:52 E.S.T.
Cellectis Reports 4th Quarter and Full Year 2017 Financial Results
Read more
08
Mar
2018
16:30 E.S.T.
Servier and Pfizer Announce Results of UCART19 First-in-Human Trials to Be Presented at the 44th EBMT (European Society for Blood and Marrow Transplantation) Annual Meeting
Read more
13
Feb
2018
00:00 E.S.T.
Two Issued U.S. Patents Granted to Cellectis for CRISPR Use in T-Cells
Read more
Prev
1
2
3
4
Next